The immunopharmacology of synthetic immunomodulators.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001388:Aziridines / Q000494:pharmacology; D004050:Ditiocarb / Q000494:pharmacology; D005936:Glucans / Q000494:pharmacology; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology; D007109:Immunity / Q000187:drug effects*; D007542:Inosine Pranobex / Q000494:pharmacology; D007369:Interferon Inducers / Q000494:pharmacology; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D007978:Levamisole / Q000494:pharmacology; D008234:Lynestrenol / Q000494:pharmacology; D009369:Neoplasms / Q000276:immunology
D000276:Adjuvants, Immunologic; D001388:Aziridines; D005936:Glucans; D007042:Hypoxanthines; D007369:Interferon Inducers; D007978:Levamisole; C016866:azimexon; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C026533:NPT 15392; D004050:Ditiocarb; D007930:Leucine; C012211:ubenimex; D008234:Lynestrenol; D007542:Inosine Pranobex